- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04039074
Effects of Yoga and Relaxation on Stress and Quality of Life
September 28, 2022 updated by: Andreas Michalsen, Charite University, Berlin, Germany
Effects of Yoga and Relaxation on Stress and Quality of Life - a Three-armed Randomized Controlled Study
The aim of this study is to measure the effects of three stress reduction methods on patients with stress and stress associated complaints.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
102
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Berlin, Germany, 14109
- Charité Hochschulambulanz für Naturheilkunde am Immanuel Krankenhaus
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- stress with at least 4 of 10 points on the Numeric Analogue Scale (NAS) at least 1 month and at least 3 of the following 8 stress symptoms: sleep disorder, inappetence or increased appetite, shoulder neck tension/back pain, tension headache, concentration disorder, exhaustion, nervousness/irritability, stress-associated digestive problems
Exclusion Criteria:
- serious acute or chronic diseases
- pregnancy or lactation
- known serious mental illness
- immobility or restriction for gymnastics exercises due to orthopaedic, neurological or other medical cause
- participation in another study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Integrative Yoga
A 12-week "Integrative Yoga" intervention which has meditative and psycho-educational components corresponding to traditional yoga practice.
|
A 12-week "Integrative Yoga" intervention which has meditative and psycho-educational components corresponding to traditional yoga practice.
|
ACTIVE_COMPARATOR: Iyengar yoga
A 12-week established, predominantly body-oriented yoga intervention (Iyengar yoga).
|
A 12-week established, predominantly body-oriented yoga intervention (Iyengar yoga).
|
ACTIVE_COMPARATOR: Mindfulness
A 12-week mindfulness intervention designed for the healthy handling of stress.
|
A 12-week mindfulness intervention designed for the healthy handling of stress.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Stress questionnaire (Cohen Perceived Stress Scale, CPSS)
Time Frame: Date of inclusion (baseline), after 12 weeks, after 24 weeks
|
Change from Baseline in the CPSS, range from 0 to 4 in each item.
Scores are obtained by reversing responses (e.g., 0 = 4, 1 = 3, 2 = 2, 3 = 1 & 4 = 0) to the positively stated items and then summing across all scale items while higher values meaning a higher grade of perceived stress.
|
Date of inclusion (baseline), after 12 weeks, after 24 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Sociodemographic Measurements
Time Frame: Date of inclusion (baseline)
|
Age, gender, education level, household income, employment status, marital status, language spoken, complete family history, current and previous illness and co-morbidities, and current medications
|
Date of inclusion (baseline)
|
Hospital Anxiety and Depression Scale (HADS)
Time Frame: Date of inclusion (baseline), after 12 weeks, after 24 weeks
|
Assessing full scale, range 0-42, lower score meaning a better outcome
|
Date of inclusion (baseline), after 12 weeks, after 24 weeks
|
Mindfulness (Freiburger Fragebogen zur Achtsamkeit, FFA)
Time Frame: Date of inclusion (baseline), after 12 weeks, after 24 weeks
|
Assessing full scale, range 0-56, higher score meaning a better outcome
|
Date of inclusion (baseline), after 12 weeks, after 24 weeks
|
Behavioral questions: alcohol consumption
Time Frame: Date of inclusion (baseline), after 12 weeks, after 24 weeks
|
Number of alcoholic beverages on average per week in the last month
|
Date of inclusion (baseline), after 12 weeks, after 24 weeks
|
Behavioral questions: relaxation
Time Frame: Date of inclusion (baseline), after 12 weeks, after 24 weeks
|
Relaxation behavior on average per week in the last month in minutes
|
Date of inclusion (baseline), after 12 weeks, after 24 weeks
|
Behavioral questions: cigarettes
Time Frame: Date of inclusion (baseline), after 12 weeks, after 24 weeks
|
Number of cigarettes on average per week in the last month in minutes
|
Date of inclusion (baseline), after 12 weeks, after 24 weeks
|
Medical Outcomes Study Short Form Quality of Life (MOS SF-36)
Time Frame: Date of inclusion (baseline), after 12 weeks, after 24 weeks
|
Assessing full scale, range 0-100, higher score meaning a better outcome
|
Date of inclusion (baseline), after 12 weeks, after 24 weeks
|
Zerssen symptom list (B-LR and B-LR')
Time Frame: Date of inclusion (baseline), after 12 weeks, after 24 weeks
|
Assessing full scale, range 20-80, higher score meaning a better outcome
|
Date of inclusion (baseline), after 12 weeks, after 24 weeks
|
International Physical Activity Questionnaire (IPAQ)
Time Frame: Date of inclusion (baseline), after 12 weeks, after 24 weeks
|
MET minutes represent the amount of energy expended carrying out physical activity.
To get a continuous variable score from the IPAQ (MET minutes a week) we will consider walking to be 3.3 METS, moderate physical activity to be 4 METS and vigorous physical activity to be 8 METS.
|
Date of inclusion (baseline), after 12 weeks, after 24 weeks
|
Maslach Burnout Inventory (MBI)
Time Frame: Date of inclusion (baseline), after 12 weeks, after 24 weeks
|
Assessing full scale, range 0-96, higher score meaning a better outcome
|
Date of inclusion (baseline), after 12 weeks, after 24 weeks
|
Aspects of Spirituality (ASP)
Time Frame: Date of inclusion (baseline), after 12 weeks, after 24 weeks
|
Assessing full scale, range 0-112, higher score meaning a better outcome
|
Date of inclusion (baseline), after 12 weeks, after 24 weeks
|
Self-Regulation
Time Frame: Date of inclusion (baseline), after 12 weeks, after 24 weeks
|
Assessing full scale, range 16-96, higher score meaning a better outcome
|
Date of inclusion (baseline), after 12 weeks, after 24 weeks
|
Multidimensional Assessment of Interoceptive Awareness (MAIA)
Time Frame: Date of inclusion (baseline), after 12 weeks, after 24 weeks
|
Assessing full scale, range 0-160, higher score meaning a better outcome
|
Date of inclusion (baseline), after 12 weeks, after 24 weeks
|
Trauma symptoms (Posttraumatic Checklist, PCL-5)
Time Frame: Date of inclusion (baseline), after 12 weeks, after 24 weeks
|
Assessing full scale, range 0-80, higher score meaning a better outcome
|
Date of inclusion (baseline), after 12 weeks, after 24 weeks
|
Mysticism Scale Short Form
Time Frame: Date of inclusion (baseline), after 12 weeks, after 24 weeks
|
Assessing full scale, range 0-32, higher score meaning a better outcome
|
Date of inclusion (baseline), after 12 weeks, after 24 weeks
|
Numerical Analog Scales
Time Frame: Date of inclusion (baseline), after 12 weeks, after 24 weeks
|
Assessing stress, back pain, headache, shoulder/neck tension, sleep quality, exhaustion, nervousness, digestive complaints, mood on 0-11 points each.
|
Date of inclusion (baseline), after 12 weeks, after 24 weeks
|
Expectation questions
Time Frame: Date of inclusion (baseline)
|
For intervention 1, intervention 2 and intervention 3 on a 6-point likert scale from 1 (very strong) to 6 (nothing at all)
|
Date of inclusion (baseline)
|
Evaluation questions
Time Frame: After 12 weeks, after 24 weeks
|
For intervention 1, intervention 2 and intervention 3 on a 6-point likert scale from 1 (very strong) to 6 (nothing at all)
|
After 12 weeks, after 24 weeks
|
Bio-electrical Impedance Analysis (BIA)
Time Frame: Date of inclusion (baseline), after 12 weeks, after 24 weeks
|
Estimation of the body composition via bio-electrical impedance analysis (muscle mass in kg)
|
Date of inclusion (baseline), after 12 weeks, after 24 weeks
|
Dietary Behaviour assessed by Food Frequency Questionaire (Gesundheit Erwachsener in Deutschland, DEGS)
Time Frame: Date of inclusion (baseline), after 12 weeks, after 24 weeks
|
Quantitative description of nutritional habits
|
Date of inclusion (baseline), after 12 weeks, after 24 weeks
|
Medication intake
Time Frame: Date of inclusion (baseline), after 12 weeks, after 24 weeks
|
Name of medication and dosage
|
Date of inclusion (baseline), after 12 weeks, after 24 weeks
|
Heart Rate Variability (HRV)
Time Frame: Date of inclusion (baseline), after 12 weeks, after 24 weeks
|
24h measuring by Faros 180 (chest)
|
Date of inclusion (baseline), after 12 weeks, after 24 weeks
|
Electrodermal Activity (Galvanic Skin Response)
Time Frame: Date of inclusion (baseline), after 12 weeks, after 24 weeks
|
24h measuring by Biovotion Everion device
|
Date of inclusion (baseline), after 12 weeks, after 24 weeks
|
Blood Volume Pulse
Time Frame: Date of inclusion (baseline), after 12 weeks, after 24 weeks
|
24h measuring by Biovotion Everion device
|
Date of inclusion (baseline), after 12 weeks, after 24 weeks
|
Respiration Rate
Time Frame: Date of inclusion (baseline), after 12 weeks, after 24 weeks
|
24h measuring by Biovotion Everion device
|
Date of inclusion (baseline), after 12 weeks, after 24 weeks
|
Interbeat Interval (IBI)
Time Frame: Date of inclusion (baseline), after 12 weeks, after 24 weeks
|
24h measuring by Biovotion Everion device
|
Date of inclusion (baseline), after 12 weeks, after 24 weeks
|
Heart Rate (HR)
Time Frame: Date of inclusion (baseline), after 12 weeks, after 24 weeks
|
24h measuring by Faros 180 (chest), Biovotion Everion
|
Date of inclusion (baseline), after 12 weeks, after 24 weeks
|
Skin Temperature
Time Frame: Date of inclusion (baseline), after 12 weeks, after 24 weeks
|
24h measuring by Biovotion Everion device
|
Date of inclusion (baseline), after 12 weeks, after 24 weeks
|
Blood Oxygenization
Time Frame: Date of inclusion (baseline), after 12 weeks, after 24 weeks
|
24h measuring by Biovotion Everion device
|
Date of inclusion (baseline), after 12 weeks, after 24 weeks
|
Body weight (kg)
Time Frame: Date of inclusion (baseline), after 12 weeks, after 24 weeks
|
24h measuring by Biovotion Everion device
|
Date of inclusion (baseline), after 12 weeks, after 24 weeks
|
Body Mass Index (kg/m2)
Time Frame: Date of inclusion (baseline), after 12 weeks, after 24 weeks
|
Date of inclusion (baseline), after 12 weeks, after 24 weeks
|
|
Waist circumference (cm)
Time Frame: Date of inclusion (baseline), after 12 weeks, after 24 weeks
|
Date of inclusion (baseline), after 12 weeks, after 24 weeks
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Qualitative interviews in focus groups interviews
Time Frame: 12 weeks after inclusion
|
Qualitative assessment will be carried out in 45-minute focus group interviews in 12 (randomized selected) patients participating in the study.
The interviews will be recorded, transcribed and analyzed with qualitative content analysis.
|
12 weeks after inclusion
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
July 29, 2019
Primary Completion (ACTUAL)
January 21, 2021
Study Completion (ACTUAL)
June 30, 2021
Study Registration Dates
First Submitted
July 28, 2019
First Submitted That Met QC Criteria
July 28, 2019
First Posted (ACTUAL)
July 31, 2019
Study Record Updates
Last Update Posted (ACTUAL)
September 29, 2022
Last Update Submitted That Met QC Criteria
September 28, 2022
Last Verified
September 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- RELAx
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stress, Psychological
-
New York State Psychiatric InstituteJohnson & JohnsonCompletedPsychological Stress in PregnancyUnited States
-
Baylor UniversityCompletedAcute Psychological StressUnited States
-
Örebro University, SwedenCompletedPsychological Stress Due to SkydivingSweden
-
Massachusetts General HospitalCompletedStress | Emotional Stress | Psychological Stress | Social Stress | Life StressUnited States
-
Amrita Vishwa VidyapeethamAmrita Viswa VidyapeethamCompletedCovid Related Psychological StressIndia
-
Institut de Recherche Biomedicale des ArmeesCompletedPsychological Stresses
-
University of California, San FranciscoNational Institute on Aging (NIA); Penn State University; Harvard UniversityCompletedStress | Depressive Symptoms | Psychological Distress | Psychological Stress | Signs and Symptoms | Psychological | Child MaltreatmentUnited States
-
Penn State UniversityStony Brook University; National Institute on Aging (NIA); Oregon State University and other collaboratorsCompleted
-
Military Academy at ETH ZurichSwiss Armed ForcesCompletedPsychological Stress | Psychological AdaptationSwitzerland
-
Nagoya City UniversityAichi Health Promotion FoundationCompleted
Clinical Trials on Integrative Yoga
-
Aarogyam UKHindu Swayamsevak Sangh (UK); Leicester Ageing TogetherCompletedChronic PainUnited Kingdom
-
Aarogyam UKUnknownChronic Pain | Psychological DistressUnited Kingdom
-
Aarogyam UKHindu Swayamsevak Sangh (UK); Leicester Ageing TogetherCompletedChronic Pain | Chronic Nonmalignant PainUnited Kingdom
-
University of FloridaSuspendedAcute Myeloid LeukemiaUnited States
-
The Canadian College of Naturopathic MedicineOttawa Hospital Research Institute; Lotte & John Hecht Memorial FoundationCompletedStomach Neoplasms | Lung Neoplasms | Esophageal NeoplasmsCanada
-
ARCIM Institute Academic Research in Complementary...CompletedPatient Satisfaction and Experience With Integrative TherapiesGermany
-
Nantes University HospitalCompleted
-
Bnai Zion Medical CenterRecruiting
-
Skidmore CollegeTerminated